Validation of the REMINDER Dementia Risk Reduction Program

Until now, neuropsychological interventions aimed to optimize cognitive function and to have functional impact in individuals at risk of AD (MCI patients) were scarce in validity studies. While some RCTs have been developed in cognitive training interventions, comparative studies of merged interventions (cognitive, social and behavioral stimulation) with adequate control groups are absent, diminishing the professionals' trust on the adoption of these interventions for supporting patients. As such, the present proposal will develop a validation trial testing a multicomponent neuropsychological intervention (REMINDER), based on personal development, cognitive compensatory aids, meaningful goals setting, and behavior change techniques. The investigators will analyze its short/long-term gains and AD conversion rates. By aiming to provide a good validation study for REMINDER, the investigators will examine neurobiological, neurocognitive and functional outcomes of this intervention in comparison with an active control group (psychoeducation) in order to foster an effective outcome assessment of an intervention for individuals at risk of AD.

NCT Number	NCT05296980
Lead Sponsor	University of Coimbra Collaborators: Fundação para a Ciência e a Tecnologia
Conditions	Healthy Aging, Risk Reduction, Old Age; Dementia
Enrollment	400 participants
Start Date	2022-04-01
Primary Completion	2024-05-02 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2024-05-08